| Literature DB >> 21818732 |
Donna Dizon-Townson1, Connie Miller, Valerija Momirova, Baha Sibai, Catherine Y Spong, George Wendel, Katharine Wenstrom, Philip Samuels, Steve Caritis, Yoram Sorokin, Menachem Miodovnik, Mary J O'Sullivan, Deborah Conway, Ronald J Wapner, Steven G Gabbe.
Abstract
Compounds that are systemically absorbed during the course of cigarette smoking, and their metabolites, affect the coagulation system and cause endothelial dysfunction, dyslipidemia, and platelet activation leading to a prothrombotic state. In addition, smoking increases the activity of fibrinogen, homocysteine, and C-reactive protein. We hypothesize that smoking may affect functional coagulation testing during pregnancy. A secondary analysis of 371 women pregnant with a singleton pregnancy and enrolled in a multicenter, prospective observational study of complications of factor V Leiden mutation subsequently underwent functional coagulation testing for antithrombin III, protein C antigen and activity, and protein S antigen and activity. Smoking was assessed by self-report at time of enrollment (<14 weeks). None of the functional coagulation testing results was altered by maternal smoking during pregnancy. Smoking does not affect the aforementioned functional coagulation testing results during pregnancy.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21818732 PMCID: PMC3770153 DOI: 10.1055/s-0031-1285097
Source DB: PubMed Journal: Am J Perinatol ISSN: 0735-1631 Impact factor: 1.862